Remote ischemic preconditioning is redundant in patients undergoing coronary artery bypass graft surgery who are already protected by volatile anesthetics

Circulation Research

Volumn 110, Issue 5, 2012, Pages

  Zaugg, Michael ^a   Lucchinetti, Eliana ^a   Clanachan, Alexander ^a   Finegan, Barry ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INHALATION ANESTHETIC AGENT; ISOFLURANE; STAT5 PROTEIN;

CORONARY ARTERY BYPASS SURGERY; DISEASE MARKER; DNA DAMAGE; FATTY ACID METABOLISM; HEART PERFUSION; HUMAN; ISCHEMIC PRECONDITIONING; LETTER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 84857802701     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.265116     Document Type: Letter

References (10)

1. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M. STAT5 Activation and Cardioprotection by Remote Ischemic Preconditioning in Humans. Circ Res. 2012;110:111-115.
2. Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol -a clinical trial. Acta Anaesthesiol Scand. 2012;56:30-38.
3. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation. 1999;100(Suppl 19):II340-II344. (Pubitemid 29523557)
4. Lucchinetti E, Bestmann L, Feng J, Freidank H, Clanachan AS, Finegan BA, Zaugg M. Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass graft surgery: Lack of synergy or evidence of antagonism in cardioprotection? Anesthesiology. 2012;116:296-310.
5. Lucchinetti E, Hofer C, Bestmann L, Hersberger M, Feng J, Zhu M, Furrer L, Schaub MC, Tavakoli R, Genoni M, Zollinger A, Zaugg M. Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology. 2007;106:444-457. (Pubitemid 46662209)
6. Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Harter L, Keel M, Meier T, Zaugg M. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology. 2007;106:262-268. (Pubitemid 46185170)
7. Vianna PT, Castiglia YM, Braz JR, Viero RM, Beier S, Vianna Filho PT, Vitoria A, Reinoldes Bizarria Guilherme G, de Assis Golim M, Deffune E. Remifentanil, isoflurane, and preconditioning attenuate renal ischemia/ reperfusion injury in rats. Transplant Proc. 2009;41:4080-4082.
8. Kuzume K, Kuzume K, Wolff RA, Chien GL, Van Winkle DM. Remifentanil limits infarct size but attenuates preconditioning-induced infarct limitation. Coron Artery Dis. 2004;15:449-455. (Pubitemid 39488771)
9. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways. Anesthesiology. 2002;97:4-14. (Pubitemid 34733916)
10. Rahman IA, Mascaro JG, Steeds RP, Frenneaux MP, Nightingale P, Gosling P, Townsend P, Townend JN, Green D, Bonser RS. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation. 2010;122(Suppl 11): S53-S59.